ロード中...
Hypomethylating Agents and Other Novel Strategies in Myelodysplastic Syndromes
Over the last decade, treatment approaches for patients with myelodysplastic syndromes (MDS) have improved significantly. Treatment of MDS is tailored to the specific risk characteristics of the patient. In general, patients are divided into lower- and higher-risk categories. Without therapy, progno...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3056493/ https://ncbi.nlm.nih.gov/pubmed/21220589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.0854 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|